Assessment of Double Screening Programmes Via Solid Substrate Fermentation (SSF) in a Flask System and Identification of Lovastatin Potential Producer by Rashid, S. A. (Syarifah) et al.
Proceedings of The 2nd Annual International Conference Syiah Kuala University 2012  
& The 8th IMT-GT Uninet Biosciences Conference 




Volume 2 Number 1, 2012 
 
Assessment of double screening programmes via solid 
substrate fermentation (SSF) in a flask system and 
identification of lovastatin potential producer 
 
1Syarifah Ab Rashid, 1Darah Ibrahim, and 2I Nyoman Pugeg Aryantha 
 
1Industrial Biotechnology Research Laboratory (IBRL), School of Biological Sciences, Universiti Sains 
Malaysia, 11800 Minden, Penang Malaysia. 2School of Life Sciences and Technology, Institut Teknologi 
Bandung, Jl. Ganesa No. 10 Bandung, Indonesia 40132 
 
Abstract. Local economical substrates namely rice bran and unprocessed brown rice was applied into fermentation 
condition to produce a potent secondary metabolite compound, lovastatin. A basis condition of fermentation viz. 70% 
(v/w) of moisture content (adjusted to pH 6.0), 1x107 spore/ml of inoculum size, mixture of 1:1 substrates and 7 days of 
incubation period, was applied into SSF system. During a preliminary test, all of 72 fungi disclosed positive dark spot onto 
the thin layer chromatography plate (TLC). In order to verify the existence of lovastatin, the secondary screening which 
involving high performance liquid chromatography (HPLC) was conducted. Out of 72, only 71 fungi were detected as 
lovastatin producers and the highest production was stated from SAR I isolate with 68.72±0.84 mg lovastatin/g dry 
substrate and 0.87±0.03 mg glucosamine/g dry substrate of fungal growth. SAR I isolate was identified via colony and 
microscopic morphologies. Through the observations, SAR I isolate was identical to Aspergillus niger.  




An estimation of 30% increment in human mortality from year 2008 to 2030 is caused by 
cardiovascular diseases (CVD). Coronary heart disease, cerebrovascular disease, peripheral 
arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis and 
pulmonary embolism are some common problems which clustered under CVD. Heart attack and 
stroke are the acute phase of those problems. The unhealthy diet, physical inactivity, harmful 
use of tobacco and alcohol are the major causes of welcoming hypercholesterolemia, an 
abnormal range of cholesterol in blood. CVD has a close relation with hypercholesterolemia as it 
is controlled by two important component (combination lipid and protein) namely low density 
lipoprotein and high density lipoprotein. Maintaining HDL level in a safe range is very crucial in 
evading CVDs problem. 
Prevention is better than cure. Some people start to live in a healthy lifestyle but when it 
comes to a hypercholesterolemia condition, mostly for those who inherit it from family, 
medications treatment is the best solution. Statins are one of the options and they are 
categorized under secondary metabolites compound. Lovastatin which also known as Mevacor or 
mevinolin was the first statin to be permitted by US Food and Drug Administration (FDA) as an 
agent for reducing cholesterol (Pansuriya and Singhal, 2010). Basicly, there are two forms of 
lovastatin; inactive lactone and acid. Lactone form will be hydrolyzed into acid form in human 
liver and transported via blood. The principal of lovastatin is to inhibit 3-hydroxy-3-methyl 
glutaryl coenzyme A (HMG CoA) in mevalonate pathway or generally in cholesterol biosynthesis 
pathway. 
The discovery of lovastatin attracted tremendous interest from scientists. At the 
beginning, only submerged fermentation (SmF) is carried out in producing this compound by 
varying the physic-nutritional parameters. But, the advantages which are offered by solid 
substrate fermentation (SSF) have urged researchers for deep surfing this system. Better 
controlling process, maximum substrate utilization, lower chances of contamination, easy 
downstream processing and etc. (Pandey et al., 2001) are some promises of SSF which allow it 
gaining popularity for multiple commercialized products including enzymes and secondary 
metabolites. A GRAS microorganism, Aspergillus niger is broadly applied for biotechnological 
application (Schuster et al., 2002). Not many reports are done regarding A. niger as lovastatin 
producer. A good news from www.uniprot.org, actually, A. niger consisted lovastatin gene known 
as lovB (a heterodimer of a nonaketide chain and a diketide) which means it can potentially 
generates lovastatin.  
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This project deals with primary and secondary screening of producers and identification 
programme for influential fungus towards lovastatin production under SSF conditions. By taking 
an advantage of rice bran and brown rice as a cholesterol lowering agent, both were used as 
substrate. 
 
Materials and Methods      
Isolation of microorganism and inoculum preparation 
All of 72 fungi used in this study were isolated from substrates (rice bran and brown rice), 
stock cultures of Industrial Biotechnology Research Laboratory (IBRL) and paddy field soils in 
Penang and Perak, Malaysia. A serial dilution was performed in order to get precise dilution for 
spread plate method. Fungi were subcultured fortnightly on potato dextrose agar (PDA) slants 
and stored at 4 0C. For inoculum preparation, 10 ml of sterile distilled water into the agar slant 
containing mature fungal culture and shake it vigorously using vortex. After diluting the 
concentrated stock serially, haemocytometer was used to determine the inoculum size.  
Solid substrate fermentation (SSF) system and Identification of the potential lovastatin 
producer  
A 1:1 ratio of rice bran and brown rice were applied into a shake flask system (250 ml). 
All cultures were grew in basis SSF condition containing 5 g substrate, 70% (v/w) distilled water 
and inoculum size of 1 x 107 spore/ml. After the inoculation with spore suspension, the flasks 
were mixed up and incubated up till 7 days at 30±2 0C. All experiments were carried out in 
triplicates and the results were presented as mean of the triplicates experiments.  
Based on colony and microscopic morphologies, the fungal identification was done. Colony 
morphology was carried out on different agar namely potato dextrose agar (PDA), malt extract 
agar (MEA), creatine agar (CREA) and czapeks yeast agar (CYA). The agars were incubated at 
temperature of 25, 30 and 37 0C for seven days. The fungal colony and agar structure (reverse 
plate) were observed.  For microscopic morphology, light and scanning electron microscope (LM 
and SEM) were used in order to observe fungal’s structural characteristics. The fungal 
characteristics were described and identification was performed based on manual described by 
Pitt and Hocking (1999) and Cappuccino and Sherman (2005). 
Extraction of lovastatin in SSF system and Thin layer chromatography as primary 
screening of lovastatin 
The fermented substrates were crushed into powder after 48 hours of drying procedure at 
60 0C. Later, 1 g of dried matter was dissolved in 30 ml acetonitrile and shake for an hour at 220 
rpm. Then, the samples were centrifuged at 3000 gravity for 10 min. 2 ml portions of aliquot 
were mixed up with 2 ml water and 50µl of concentrated phosphoric acid before filtered through 
nylon syringe filter (pore size of 0.45 µm). The filtered samples were subjected onto thin layer 
chromatography (TLC) plate and high performance liquid chromatography (HPLC) for analysis 
purpose (Szakacs et al., 1998). 
20 x 20 cm Merck silica gel 60F254 TLC plate was used to detect lovastatin presence 
(Samiee et al., 2003). The extracted sample was spotted on the plate and soaked into a mixture 
of dichloromethane and ethyl acetate (70:30; v/v). All the plates were observed under a hand-
held UV lamp (254 nm) and then stained with iodine vapor. The retention factor (Rf) was 
measured and compared with the standard (purity of 99.7%). 
Quantification of lovastatin by HPLC and Fungal growth detection 
An active form of lovastatin was measured using Waters HPLC which was supplied with 
Symmetry C18 column (4.6 mm x 250 mm, 5 µm pore). Acetonitrile and phosphoric acid (pH 3.0) 
were used as the mobile phase. The ratio used was 77:23 (v/v), respectively. The retention time 
between standard and samples were compared to identify lovastatin. 
Method of Tsuji et al., (1969) and Swift (1973) was applied in order to determine fungal 
growth. Chitin in cell wall was hydrolyzed and converted into glucosamine before been detected 
at 530 nm. 
 
Results and Discussion 
All of 72 fungi namely C2-1, tempeh, New, BS1, Aspergillus flavus, C4-2, B2-2, 
Trichophyton mentagophytes, Trichoderma reesei, ED25, Trichophyton rubrum, KB1, F4, FI3, 
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KB2, BI, P1, II2, BS2, EI3, Aspergillus fumigatus, B3-4, RBS1, Penicillium roquefortii ITB, B1-2, 
BS3, C4-1, Trichoderma viridae, Aspergillus nidulans, PBK2-2, PBK1-3, H36, B2-1, BS4, B2-6, 
Collectotrichum sp, KB3, KB4, Rhizopus sp, 7(1), BS5, PBK1-1, 7(14), K5-5, Penicillium sp, 
ED24, NR, BS6, KB5, SAR I, ED19, Gliocladium roseum, ED16, P2, K3-4, P3, Penicillium citrinum 
ITB, AI1, BS7, B3-2, D3-5, KC, 7(2), P4, KB6, KB7, KB8, 7(13), P5, P6, P7 and C3 depicted a 
dark spot which was appeared at almost the same level of standard spot. The Rf for all samples 
were ranged of 0.19 to 0.39. Primary screening by TLC only reported on compound polarity. As 
for lovastatin, it was slightly non-polar compound because it has less affinity towards stationery 
phase. 
In this experiment, the retention time (Rt) for acid was 5.5±0.2 min. From the Rt, the 
activity of lovastatin can be determined. Only 71 fungi depicted positive and active lovastatin 
compound. Among the fungi, isolate SAR I displayed the highest activity which was 68.72±0.84 
mg lovastatin/g dry substrate and 0.87±0.03 mg glucosamine/g dry substrate of fungal growth. 
While isolate K5-5 gave no lovastatin activity at all.  
As isolate SAR I gave the highest production, it was solely selected for identification. The 
colony was black and spread rapidly on PDA while from the reverse plate view, the agar changed 
from smooth into wavy structure (only at the inoculation area). Those characteristics were 
observed after seven days incubation at 25, 30 and 37 0C. Generally for MEA, the same condition 
was reported but the agar became wavier compared to PDA. There was also rapid black spore 
spreading on CYA during 25 and 30 0C, but, a slow pattern was showed during 37 0C. The 
mixture of spore (at the central of inoculation point) with white mycelium was clearly made a 
different outcome compared to PDA and MEA. CREA was a special agar to detect the ability of the 
fungal isolate whether it can produce acid or not. The positive result for acid production will 
expose if the agar color change from purple to yellow. In this experiment, SAR I isolate did 
produce acid (Figures were not shown). 
A matured SAR I isolate was further identified via microscopes (LM and SEM). Figure 1.0 
described the observation under LM. This fungal consisted a long conidiophore, globose vesicle 
(to hold the conidium chain) and also conidia (Cappuccino and Sherman, 2005). While for SEM 
view (Figure 2.0), it was more interpreted as the colorless conidiophore elongated up to 3.0 mm, 
globose vesicle with 50-75 µm diameter plus rough and wavy surface of conidia (4 -5 µm 
diameter) with radiate head. It was all reported by Pitt and Hocking (1999). With these 
elaborations, those morphologies were very identical to Aspergillus niger.    























Figure 2. The scanning electron microscope result of SAR I isolate indicated more detail structural characteristics 
compared to LM 
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Conclusions 
A slight non polar of lovastatin by various fungi was discover via TLC and then was 
verified by HPLC. SAR I isolate which was later identified as A. niger, gave the highest production 
of anti cholesterol agent (lovastatin) under SSF system.  
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